Utility of an improved model of amyloid-beta (A beta(1-42)) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease
Gawain McColl, Blaine R Roberts, Tara L Pukala, Vijaya B Kenche, Christine M Roberts, Christopher D Link, Timothy M Ryan, Colin L Masters, Kevin J Barnham, Ashley I Bush, Robert A Cherny
Molecular Neurodegeneration | BMC | Published : 2012
We thank Leanne Taylor and Ian Birchall (FNIMH) for assistance with histology, Monica Lind (FNIMH) for technical assistance and Nicole Jenkins for comments. Nematode strains used include some provided by the Caenorhabditis Genetics Center funded by the U. S. National Institutes of Health National Center for Research Resources. We acknowledge support by the Victorian Government Operational Infrastructure Support Program.